ABBV - Aldeyra gains on plans for AbbVie-partnered eye disease drug
2024-03-28 13:42:43 ET
More on Aldeyra Therapeutics
- Aldeyra: Derisked Biotech Eyeing Path To Approval And Finalizing Deal With AbbVie
- Why Aldeyra Therapeutics Is A Strong Buy: AbbVie Agreement And Reproxalap's Prospects
- Seeking Alpha’s Quant Rating on Aldeyra Therapeutics
- Historical earnings data for Aldeyra Therapeutics
- Financial information for Aldeyra Therapeutics